shelves of high street pharmacies, supermarkets and health food shops clearly illustrate the growth in the herbals market, with ever wider ranges of products on display. A Consumers' Association Survey indicated that in 1993 more than £60 million was spent on over-the-counter alternative medicines in the UK. In 1994 the European herbal medicine market was worth over £1.8 billion at retail selling prices4. Although the UK market is at present smaller than that of Germany (in 1994 it was £88 million, compared with £1400 million) it has one of the highest forecast growth rates in Europe at 16% to 19995. Apart from European products there has been a big increase in imports of products from the US, Australia and Asia.
Amongst the general public there is growing acceptance of the medical herbalist philosophy, with its emphasis on holistic treatment. Despite some adverse publicity, it is perceived as having fewer side-effects than allopathic medicine. In a survey of US consumers in 1997, 53% thought herbal remedies were at least as effective as nonherbal remedies, and 65% considered them safer3. Studies in Europe have shown the effectiveness of some herbs such as garlic. Ginkgo biloba, a peripheral vasodilator, is one of the top physician-prescribed products in Germany6. In this paper we look at the safety aspects, not efficacy.
UK LEGISLATION AND CONSUMER PERCEPTION
In the UK the legal status of herbal remedies/medicines can be broadly divided into three categories: In 1996 the Medicines Control Agency included adverse reaction reports on unlicenset1 herbal remedies into its remit, and it now monitors all three categories. The distinction between the categories, and its implications for product quality, safety and efficacy, is not necessarily apparent either to medical professionals or to consumers. The consumer's perception of food supplements and herbal remedies is undoubtedly confused. The easy availability of these products through supermarkets is likely to increase the perception that they are wholly safe. Where they are purchased alongside the weekly food the staff of the store are not required to have any specialized knowledge; and, with this method of purchase, there is lesser likelihood that medical professionals will be told about use of these products. Patients we interviewed in a general practitioner's surgery did not consider the supplements they were using to be worthy of mention to the doctor. But in a Consumers' Association survey, 40% of consumers judged a selection of herbal and other supplements to be medicines whereas only 26% thought they were foods7. Two products that were regarded as medicines by most consumers were garlic capsules (48%) and red wine extract (54%).
PRODUCT QUALITY AND IDENTITY
When we look at the safety or efficacy of herbal remedies, quality is a key element. Except with licensed products there is no guarantee that the herbal material used in preparation of the product was of good quality, free from contaminants or correctly identified. Quality is inextricably bound to safety. Contaminants accumulated during production or in long-term storage, such as pesticides or aflatoxins, potentially cause serious health effects. Some products may not contain the plant declared on the label. A safe herb may be replaced by an incorrect species, resulting in loss of efficacy, or, of more concern, unexpected adverse effects. Such adulteration complicates adverse reaction monitoring since the wrong plant may be investigated, and documented effects may be associated with the wrong herb. For example, adulteration or substitution may be responsible for the adverse reaction reports on kava and skullcap. When skullcap (Scutellaria laterflora) was suspected of hepatotoxicity, samples of this herb were found to be substituted with American germander (Teucrium canadense)8. At that time there were no pre-existing reports of skullcap hepatotoxicity, whereas the mechanism of hepatotoxicity had been elucidated for another species of germander T. chamaedrys9. In another incident about 50 people experienced dizziness, severe shortness of breath and respiratory arrest (most requiring hospitalization) after using a product said to contain kava (Piper methysticum). This herb is approved in Germany as a safe non-prescription medication and is not usually associated with these symptoms. Subsequent analysis showed that the product contained 1,4 butanediol and caffeine (not listed on the label) but no kava10.
Another aspect of quality and safety is that of variable extract type. Some herbal products consist of crushed herbs, while others are aqueous or alcoholic extractions dried down into capsules or pills. It can be difficult to compare products or estimate equivalent doses where the type of extract is not known, and people who change brands may find they get more or less of the active ingredient in a single dose. The herbal industry is introducing a code of practice which includes quality standards for unlicensed products. However, it is difficult to see how such a voluntary code will be enforced without legislative support, in view of the proliferation of products in shops, to say nothing of mail order, pyramid sales and imported remedies.
RESTRICTED INGREDIENTS
Various regulatory Acts and Statutory Instruments control the availability of certain herbs in the UK. Many herbs are on the General Sales List and these are regarded as safe in over-the-counter products. S12130 stipulates herbs that are to be supplied only by medical professionals or herbal practitioners. However, regulations are different in other countries, and products imported from the US, the Indian subcontinent and China have been found to contain restricted ingredients. For example, ephedra (Ma huang), yohimbe and chapparal are available in dietary supplements in the US. In the UK these are, respectively, pharmacyonly, prescription-only and under voluntary withdrawal.
TRADITIONAL MEDICINES FROM CHINA AND THE INDIAN SUBCONTINENT
Countries such as China and India have extensive and well developed systems of traditional medicine. However, their medicines may include ingredients that are judged toxic, or restricted, in the UK. There have been numerous reports of trace elements such as lead in traditional medicines from the Indian subcontinentll. Under their belief system these are not considered toxic when oxidized. Arsenic and mercury Pharmaceuticals have been found in both Indian and Chinese medicines, and are sometimes on the ingredient list. In the UK some of these, such as diazepam or phenacetin, are either prescription-only or have been withdrawn from sale13. Such supply of pharmaceuticals is not legal. The importation of these products is difficult to prevent since many are brought back by people visiting relatives or travelling in other countries. Reduction of supply may be best achieved by educating suppliers and practitioners concerning the legal implications of using such medicines. There is also a considerable herbal component in these traditional systems, and the reported benefits should not be overlooked because of concern about potential traceelement or pharmaceutical toxicity.
HERBAL PRODUCT USE AND ABUSE
After product quality, the next safety issue to be considered is customer or patient use. The main sources open to the consumer/patient are, firstly, herbal products that are selfprescribed from health food shops, supermarkets, mailorder or pyramid selling and, secondly, herbal medicines prescribed by a herbal practitioner for a specific patient.
It is the former group that seems most open to general misuse and abuse. These products are the subject of glossy advertisements, and articles on health and diet promote their use. Where these products are selected off the shelf in health food shops or purchased alongside the weekly supermarket shopping, consumers may forget that they must be used with caution and the instructions must be followed. Incorrect or inappropriate use takes several forms. Inappropriate use includes unnecessary treatment and use of incorrect herbs for the ailment. Patients who decide to self-treat may delay seeking medical advice for potentially serious conditions, and they may also stop taking drugs in favour of alternatives. Consumers often believe that if something is a natural supplement, reportedly beneficial to health, an increase in the dose will enhance the benefit. This can lead to either acute or chronic overdose. Overdose can also result from the use of multiple products where there may be a common ingredient. Interactions can occur between ingredients or products. We have investigated cases in which combinations of up to twelve different products had been regularly used.
Apart from interactions between products there is potential for interactions with pharmaceuticals. Some herbs contain cardiac glycosides, others contain platelet activating factor inhibitors. So far this area has been poorly documented and investigated. Matters become more difficult when patients do not tell their general practitioner they are using herbal remedies or traditional medicines, or the herbalist that they are using pharmaceuticals. Contraindications are rarely included on the labels, and because the products are natural, people may think that such precautions do not apply. For example, with ginseng (Panax ginseng) the usual advice is not to take it with caffeine and similar stimulants8. However, in many herbal products it is promoted as a stimulant and combined with guarana or kola nut, both of which contain substantial amounts of caffeine.
HERBAL PRACTITIONERS
The other source of herbal medicines is herbal practitioners, many of whom are well trained and highly professional. In the UK, medical herbalists use mostly European or North American herbs. Many other traditional systems are also represented including Ayurvedic, Unani, Chinese herbal medicine, Tibetan and African. At present there are no regulations over who may practise as a herbalist in the UK. Despite the existence of colleges and even university degree courses, there are no statutory requirements for minimum training. Several registers of qualified herbalists have codes of practice and standards of training; however, since such registration is not compulsory, the standards cannot be universally enforced. All of which makes it difficult for members of the public to identify properly trained herbalists. The herbal practitioner community in the UK has long recognized the need for occupational registration and formed the British Herbal Practitioners Association to promote this aim. If this is achieved minimum standards of training and codes of practice will be set. Use of more potent herbs, currently exempt under the Medicines Act, will also be better controlled.
COMMUNICATION AND INFORMATION
Despite these potential drawbacks many people believe they derive real benefit from herbal and traditional remedies. Supportive evidence has also come from clinical trials-for example, Chinese herbal medicine for eczemal4. Unfortunately some patients are reluctant to inform doctors that they are using herbal or traditional medicines, for fear of an unfavourable reaction. In some extreme cases, it has not been until herbal toxicity has progressed to liver or renal failure that use of these medicines has been admitted. There is a need to maintain communication between patients, doctors and herbal practitioners. This area is not part of the medical curriculum and doctors do not have time to search for the appropriate information when advice is sought. An independent information source bringing together published safety and efficacy data along with that collected by adverse reaction monitoring systems is required for use by m¢dical professionals and herbal practitioners. This has, in part, been one of the aims of our Traditional Medicine Project at the Medical Toxicology Unit.
The project has been monitoring adverse reactions to herbal medicines since 199113. Overall, we have found these remedies safe when compared with orthodox medicine, but there are areas of concern. The constituents of Chinese herbal medicines are often crude, and we have assisted doctors by identifying the herbal material and providing toxicity information and general background information on Chinese medicine. We have tried to bring together data that will enable patients and practitioners to make a good risk/benefit assessment before using any herbal or traditional medicine, and have provided support in the evaluation of adverse reactions. In October, the Prince of Wales launched the discussion document Integrated Healthcare, encouraging greater access and research into alternative medicine, including herbal medicinel5. To support these aims, regulation of herbal practitioners and herbal products is required. Occupational registration for practitioners would ensure training and practice standards. Regulation of products may be best achieved by introduction of a separate regulatory category taking into account that herbal remedies are not truly foods but are also distinct from pharmaceuticals. Such a category, requiring all herbal products to comply with a single set of quality standards before being marketed, would substantially reduce the sale of poor-quality products and those with potentially toxic constituents.
